Latest Advances

  • Condition: Granulomatosis with Polyangiitis (GPA) in Eyelid
  • Journal: Medicine
  • Treatment Used: Radiotherapy
  • Number of Patients: 0
  • Published —
This case report describes a 29-year-old man diagnosed with granulomatosis with polyangiitis (chronic blood vessel inflammation) occurring in the eyelid treated with radiotherapy.
  • Condition: Exacerbation of a Severe Eosinophilic Asthma Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • Journal: BMC pulmonary medicine
  • Treatment Used: Benralizumab
  • Number of Patients: 1
  • Published —
This article reviewed the effects of benralizumab in exacerbation (worsening) of severe eosinophilic asthma (type of severe asthma marked by high levels of white blood cells) associated with eosinophilic granulomatosis with polyangiitis (rare autoimmune condition that causes inflammation of small and medium-sized blood vessels in persons with a history of airway allergic hypersensitivity; EGPA).
  • Condition: Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Systemic Vasculitis (AAV)
  • Journal: Arthritis research & therapy
  • Treatment Used: Plasma Exchange (PE)
  • Number of Patients: 964
  • Published —
This study assessed the effectiveness of plasma exchange (removal, treatment, and return or exchange of blood plasma; PE) for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (inflammation of small vessels; AAV).
  • Condition: Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Autoimmunity reviews
  • Treatment Used: Rituximab
  • Number of Patients: 171
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of eosinophilic granulomatosis with polyangiitis.
  • Condition: Granulomatosis with Polyangiitis
  • Journal: BMJ case reports
  • Treatment Used: Avacopan
  • Number of Patients: 1
  • Published —
This study reports a case of a patient with granulomatosis with polyangiitis (GPA) who was treated with avacopan, a novel C5a receptor inhibitor, after conventional therapies were not working.
  • Condition: Anti-Neutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Anti-Cytokine Targeted Therapy
  • Number of Patients: 440
  • Published —
This study tested the safety and efficacy of using anti-cytokine targeted therapy to treat patients with ANCA-associated vasculitis.
  • Condition: False Positive COVID-19 Antibody Test in Patient with Granulomatosis With Polyangiitis (GPA)
  • Journal: Frontiers in medicine
  • Treatment Used: Methylprednisolone Pulses and Cyclophosphamide
  • Number of Patients: 1
  • Published —
This case report describes an 82-year-old female with granulomatosis with polyangitis (GPA) who had a false positive COVID-19 antibody test and was treated with methylprednisolone pulses and cyclophosphamide.
  • Condition: Microscopic Polyangiitis (MPA) and Granulomatosis with Polyangiitis (GPA)
  • Journal: Yonsei medical journal
  • Treatment Used: Rituximab Biosimilar
  • Number of Patients: 139
  • Published —
This study investigated the effects of rituximab on poor outcomes for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).
  • Condition: Peripheral Neuropathy in Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Journal of immunology research
  • Treatment Used: Glucocorticoids with Immunosuppressants
  • Number of Patients: 0
  • Published —
The study researched the prevalence of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis.
  • Condition: Granulomatosis with Polyangiitis (GPA)
  • Journal: PloS one
  • Treatment Used: Mycophenolic Acid and 6-Mercaptopurine
  • Number of Patients: 85
  • Published —
This study investigated whether mycophenolate-mofetil (MMF) or azathioprine (AZA) alters the circulating B-cell distribution, proliferation, and cytokine production in patients with granulomatosis with polyangiitis (small blood vessel disease; GPA).
  • Condition: ANCA-Associated Vasculitis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Rituximab
  • Number of Patients: 188
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of relapsing ANCA-associated vasculitis.
  • Condition: Antibody-associated Vasculitis
  • Journal: Annals of internal medicine
  • Treatment Used: Rituximab
  • Number of Patients: 97
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of antibody-associated vasculitis.
Showing 1-12 of 41